MOF enhances the sensitivity and selectivity of sorafenib as an anticancer drug against hepatocellular carcinoma and colorectal cancer in vitro

E Emad M. Elzayat N Nadeen M. Hassan R Rehab Mahmoud E Essam Ibrahim N Nourhan Hassan

Article Details

Volume / Issue Vol. 15, Issue 1
Published September 18, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (5)

E

Emad M. Elzayat

N

Nadeen M. Hassan

R

Rehab Mahmoud

E

Essam Ibrahim

N

Nourhan Hassan